Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

AZNCF

AstraZeneca (PK) (AZNCF)

AstraZeneca Plc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:AZNCF
DateTimeSourceHeadlineSymbolCompany
03/07/20245:34AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
03/07/20245:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
03/06/20249:11AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
03/06/20249:06AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
03/06/20246:21AMEdgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingUSOTC:AZNCFAstraZeneca Plc (PK)
03/05/20243:40PMEdgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]USOTC:AZNCFAstraZeneca Plc (PK)
03/04/20245:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
03/01/20249:39AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/22/20245:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/21/20247:32AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
02/21/20247:13AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:AZNCFAstraZeneca Plc (PK)
02/21/20245:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20244:19PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansUSOTC:AZNCFAstraZeneca Plc (PK)
02/20/20243:34PMEdgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20243:22PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20248:25AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20246:51AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20246:49AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20246:12AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20245:52AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20245:47AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/20/20245:27AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/12/20249:13AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AZNCFAstraZeneca Plc (PK)
02/08/20245:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
02/01/20249:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
12/14/20239:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
12/12/20234:15PMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyUSOTC:AZNCFAstraZeneca Plc (PK)
12/12/20234:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
12/12/20235:26AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
12/01/202310:53AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:AZNCFAstraZeneca Plc (PK)
 Showing the most relevant articles for your search:USOTC:AZNCF